Anti-PD-1/L1-associated immune-related adverse events as harbinger of favorable clinical outcome: systematic review and meta-analysis

JOURNAL ARTICLE published January 2021 in Clinical and Translational Oncology

Authors: R. Park | L. Lopes | A. Saeed